deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04695704

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: (E-SPERANZA)

Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: E-SPERANZA COVID-19 PROJECT

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Conditions Covid19 SARS (Disease)
Interventions Montelukast placebo
Updated 8 times since 2021 Last updated: Jul 1, 2024 Started: Aug 11, 2021 Primary completion: Jul 24, 2023 Completion: Aug 28, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The incidence of respiratory Long COVID has decreased in the new waves, thus made impossible to achieve the required study sample.

Other terminated trials from Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

See all terminations from Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Other Covid19 trials with similar outcome

Browse all Covid19 trials

Listed as NCT04695704, this PHASE3 trial focuses on Covid19 and SARS (Disease) and remains terminated or withdrawn. Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, it has been updated 8 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshotNot Yet Recruiting~Apr 2021 – ~Jul 2022 · 15 months · monthly snapshotNot Yet Recruiting~Jul 2022 – ~Mar 2023 · 8 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotRecruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotUnknown~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Aug 2024 — Sep 2024 [monthly]

    Terminated PHASE3

    Status: Unknown → Terminated

  4. Jul 2024 — Aug 2024 [monthly]

    Unknown PHASE3

    Status: Recruiting → Unknown

  5. Mar 2023 — Jul 2024 [monthly]

    Recruiting PHASE3

▶ Show 3 earlier versions

  1. Jul 2022 — Mar 2023 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  2. Apr 2021 — Jul 2022 [monthly]

    Not Yet Recruiting PHASE3

  3. Feb 2021 — Apr 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
  • Institut Català de la Salut
Data source: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations